Successful Conversion Surgery Following S-1 Plus Oxaliplatin Combined with Nivolumab Therapy for a Preoperatively Diagnosed Gastric Adenocarcinoma with Enteroblastic Differentiation: A Case Report
Stage IV GAED is associated with a poor prognosis; however, the advent of immune checkpoint inhibitors has expanded treatment options for these patients. In this case, we propose a personalized treatment strategy for GAED with peritoneal metastases that may improve clinical outcomes.
Authors
- Ken Eto (ORCID: https://orcid.org/0000-0002-3628-4493)
- Naoto Takahashi (ORCID: https://orcid.org/0000-0002-6758-3787)
- Yoshitaka Ishikawa (ORCID: https://orcid.org/0000-0001-6258-525X)
- Fumiaki Yano (ORCID: https://orcid.org/0000-0001-6682-4166)
- Sanjeev Handa (ORCID: https://orcid.org/0000-0002-1486-7161)
- Mizuki Fukuda (ORCID: https://orcid.org/0000-0003-4430-7912)
- Keiko Sasuga
- Naoki Toya (ORCID: https://orcid.org/0000-0001-9875-2865)
- Syun Sato
Institutions
- Jikei University School of Medicine (JP)
- Jikei University Kashiwa hospital (JP)
Publication Details
- Journal
- Surgical Case Reports
- Published
- 2025-01-01
- DOI
- https://doi.org/10.70352/scrj.cr.24-0134
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00